USFDA mulls to approve first ever OTC birth control pill
|
Overview
Amid the US Supreme Court's decision to ban abortion in the country, the Food and Drug Administration is considering to approve the first-ever over the counter (OTC) birth control pill.
Two companies -- French drugmaker HRA Pharma and US-based Cadence Health -- have approached the FDA to authorise their pill for OTC-sales in the US.
HRA Pharma has applied for an Rx-to-OTC switch for Opill, a progestin - only daily birth control pill (also referred to as a mini pill or non-estrogen pill).
For more details, check out the full story on the link below:
USFDA Mulls To Approve First-Ever OTC Birth Control Pill
Speakers
Rahul Verma joined Medical Dialogues in the year 2022 and is currently working as a Video editor & Medical correspondent. He has completed his graduation in Bachelors of Arts (BA) from IGNOU. He likes to keep himself and the world updated on the occurring in the medical field. He can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
